LinkOPH

DENVER — At the Association for Research in Vision and Ophthalmology meeting here, Arshad Khanani, MD, discusses a subgroup analysis of patients being treated with ranibizumab for wet-AMD with differing degrees of pigment epithelial detachment at 24 months of treatment. Among the findings of the study, Khanani found a three-times greater risk of macular atrophy in those patients whose PED had completely resolved at 24 months, than those patients who still had persistent PED at 24 months.

Read more →

DENVER — At the Association for Research in Vision and Ophthalmology meeting here, Ronald D. Frenkel, MD, discusses an analysis of vision in patients being treated for wet-AMD with ranibizumab at 2 years. He found that low-luminance visual acuity gains were greater than the gains made under normal lighting conditions.

Read more →